BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Medina López RA, Rivero Belenchon I, Mazuecos-Quirós J, Congregado-Ruíz CB, Couñago F. Update on the treatment of metastatic renal cell carcinoma. World J Clin Oncol 2022; 13(1): 1-8 [PMID: 35116228 DOI: 10.5306/wjco.v13.i1.1]
URL: https://www.wjgnet.com/2218-4333/full/v13/i1/1.htm
Number Citing Articles
1
Weipu Mao, Keyi Wang, Wentao Zhang, Shuqiu Chen, Jinbo Xie, Zongtai Zheng, Xue Li, Ning Zhang, Yuanyuan Zhang, Haimin Zhang, Bo Peng, Xudong Yao, Jianping Che, Junhua Zheng, Ming Chen, Wei Li. Transfection with Plasmid-Encoding lncRNA-SLERCC nanoparticle-mediated delivery suppressed tumor progression in renal cell carcinomaJournal of Experimental & Clinical Cancer Research 2022; 41(1) doi: 10.1186/s13046-022-02467-2
2
Liwen Ren, Yihui Yang, Wan Li, Hong Yang, Yizhi Zhang, Binbin Ge, Sen Zhang, Guanhua Du, Jinhua Wang. Recent advances in epigenetic anticancer therapeutics and future perspectivesFrontiers in Genetics 2023; 13 doi: 10.3389/fgene.2022.1085391
3
Martina Catalano, Luigi Francesco Iannone, Federica Cosso, Daniele Generali, Enrico Mini, Giandomenico Roviello. Combining inhibition of immune checkpoints and PARP: rationale and perspectives in cancer treatmentExpert Opinion on Therapeutic Targets 2022; 26(11): 923 doi: 10.1080/14728222.2022.2158813